NO974567D0 - 9-substituerte porfycener - Google Patents

9-substituerte porfycener

Info

Publication number
NO974567D0
NO974567D0 NO974567A NO974567A NO974567D0 NO 974567 D0 NO974567 D0 NO 974567D0 NO 974567 A NO974567 A NO 974567A NO 974567 A NO974567 A NO 974567A NO 974567 D0 NO974567 D0 NO 974567D0
Authority
NO
Norway
Prior art keywords
porphycenes
substituted
substituted porphycenes
compounds
aralkyl
Prior art date
Application number
NO974567A
Other languages
English (en)
Other versions
NO974567L (no
Inventor
Emanuel Vogel
Martin Mueller
Otto Halpern
Alexander D Cross
Original Assignee
Cytopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytopharm Inc filed Critical Cytopharm Inc
Publication of NO974567D0 publication Critical patent/NO974567D0/no
Publication of NO974567L publication Critical patent/NO974567L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO974567A 1995-04-06 1997-10-02 9-substituerte porfycener NO974567L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/418,118 US5610175A (en) 1995-04-06 1995-04-06 9-Substituted porphycenes
PCT/US1996/004177 WO1996031452A1 (en) 1995-04-06 1996-04-04 9-substituted porphycenes

Publications (2)

Publication Number Publication Date
NO974567D0 true NO974567D0 (no) 1997-10-02
NO974567L NO974567L (no) 1997-11-19

Family

ID=23656794

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974567A NO974567L (no) 1995-04-06 1997-10-02 9-substituerte porfycener

Country Status (8)

Country Link
US (1) US5610175A (no)
EP (1) EP0837839A4 (no)
JP (1) JPH11503159A (no)
AU (1) AU708597B2 (no)
CA (1) CA2214411A1 (no)
FI (1) FI973894A (no)
NO (1) NO974567L (no)
WO (1) WO1996031452A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998015271A1 (en) * 1996-10-09 1998-04-16 Emanuel Vogel 9-substituted porphycenes
US6183727B1 (en) 1998-05-19 2001-02-06 Arizona Board Of Regents Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
US6107326A (en) * 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
US6627288B1 (en) 2000-08-10 2003-09-30 Mitsui Chemicals, Inc. Optical recording medium and porphycene compound
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
JP5190865B2 (ja) * 2007-08-23 2013-04-24 国立大学法人九州大学 ブロモ化ポルフィセン誘導体及びそれを含有する光線力学治療剤
WO2015197510A1 (en) * 2014-06-23 2015-12-30 Institut Químic De Sarriá, Cets Fundació Privada Near-infrared fluorogenic porphycene derivatives as fluorescent labels for photodiagnosis and phototherapeutic use
CN110483531B (zh) * 2019-08-29 2020-08-04 李德芳 一种水溶性卟啉烯衍生物、制备方法、抗肿瘤药物和应用
CN113307813B (zh) * 2021-04-16 2022-08-23 王雨之 一种深红外卟啉烯衍生物、制备方法、抗肿瘤药物和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4452747A (en) * 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5015478A (en) * 1988-08-15 1991-05-14 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
US5262401A (en) * 1991-06-28 1993-11-16 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis

Also Published As

Publication number Publication date
JPH11503159A (ja) 1999-03-23
EP0837839A2 (en) 1998-04-29
FI973894A0 (fi) 1997-10-06
US5610175A (en) 1997-03-11
NO974567L (no) 1997-11-19
CA2214411A1 (en) 1996-10-10
EP0837839A4 (en) 2000-10-04
AU5528196A (en) 1996-10-23
FI973894A (fi) 1997-10-06
AU708597B2 (en) 1999-08-05
WO1996031452A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
ES2134847T3 (es) Derivados de taxol.
DE69807074D1 (de) Substituierte 1,2,4-triazolo[3,4,-a]phthalazin-derivate als gaba-alpha 5-liganden
AU6613896A (en) Chemical compounds
EA199900620A1 (ru) Фталазиноны
BR9808491A (pt) Compostos calcilìticos
EA199800667A1 (ru) Новые фенантридины
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
BR9711586A (pt) Compostos e uso dos mesmo
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
CA2335514A1 (en) Alkyl ether analogs of chlorins having an n-substituted imide ring
NO974567D0 (no) 9-substituerte porfycener
DE69527108D1 (de) Mikrofeine Lichtquelle
AU7095587A (en) 1,4-diazepines
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
DE69632936D1 (de) Verwendung von Pyrrolverbindungen als Antifouling-Wirkstoff
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
DE69409758D1 (de) Herstellung von Alkyl-Tert-Alkylethern
DE68926960D1 (de) Reaktive gehinderte aminlichtstabilisatoren
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
ES2098338T3 (es) Heteroarilmetilbencenos.